Why Tirzepatide Works Well
The SURMOUNT-4 phase 3 clinical trial, led by researchers at Weill Cornell Medicine and NewYork-Presbyterian, investigated the effectiveness of anti-obesity drugs, particularly tirzepatide, in maintaining weight loss over the long